S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q1 2021

Avoro Capital Advisors

Periodo: Q1 2021 Β· Depositato: 2021-05-17
Vedi su SEC EDGAR β†—
AUM
$5.79B
Valore totale del portafoglio
Posizioni
46
Titoli dichiarati
Prima Posizione
HZNP
14.3% $828.4M
Var. Trimestrali
+7 / -5
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-05-17) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
HZNPHORIZON THERAPEUTICS PLC$828.4M14.31%β€”β€”
14.3%
MRTXMIRATI THERAPEUTICS INC$800.8M13.83%β€”β€”
13.8%
UTHRUNITED THERAPEUTICS CORP$501.8M8.67%$167.27$555.91+232.3%
8.7%
XLRNACCELERON PHARMA INC$406.8M7.03%β€”β€”
7.0%
VRTXVERTEX PHARMACEUTICALS INC$300.9M5.20%$214.89$528.04+145.7%
5.2%
ARNAARENA PHARMACEUTICALS INC$281.0M4.85%β€”β€”
4.8%
ARGXARGENX SE$254.9M4.40%$275.39$939.68+241.2%
4.4%
IOVAIOVANCE BIOTHERAPEUTICS INC$253.3M4.37%$31.66$4.31-86.4%
4.4%
ASCENDIS PHARMA$244.9M4.23%β€”β€”
4.2%
MDGLMADRIGAL PHARMACEUTICALS INC$166.7M2.88%$116.97$528.10+351.5%
2.9%
SRPTSAREPTA THERAPEUTICS INC$160.2M2.77%$74.53$19.28-74.1%
2.8%
BMRNBIOMARIN PHARMACEUTICAL INC$124.6M2.15%$75.51$58.99-21.9%
2.1%
FOLDAMICUS THERAPEUTICS INC$121.0M2.09%β€”β€”
2.1%
KURAKURA ONCOLOGY INC$113.1M1.95%$28.27$11.10-60.7%
1.9%
MRSNMERSANA THERAPEUTICS INC$110.0M1.90%β€”β€”
1.9%
ADVMADVERUM BIOTECHNOLOGIES INC$78.9M1.36%β€”β€”
1.4%
PMVPPMV PHARMACEUTICALS INC$77.6M1.34%$32.89$1.22-96.3%
1.3%
CNSTCONSTELLATION PHARMACEUTICALS INC$69.0M1.19%β€”β€”
1.2%
XENEXENON PHARMACEUTICALS INC$65.3M1.13%$17.90$60.96+240.6%
1.1%
ACADACADIA PHARMACEUTICALS INC$64.5M1.11%$25.80$25.97+0.7%
1.1%
TRILLIUM THERAPEUTICS INC$61.2M1.06%β€”β€”
1.1%
SNDXSYNDAX PHARMACEUTICALS INC$55.9M0.97%$22.36$21.82-2.4%
1.0%
RLMDRELMADA THERAPEUTICS INC$53.7M0.93%$35.21$6.28-82.2%
0.9%
MRNSMARINUS PHARMACEUTICALS INC$50.1M0.86%β€”β€”
0.9%
PRAXPRAXIS PRECISION MEDICINES INC$47.4M0.82%$491.40$318.52-35.2%
0.8%
CBAYCYMABAY THERAPEUTICS INC$46.8M0.81%β€”β€”
0.8%
ISEEIVERIC BIO INC$44.8M0.77%β€”β€”
0.8%
APLSAPELLIS PHARMACEUTICALS INC$42.9M0.74%$42.91β€”
0.7%
DCPHDECIPHERA PHARMACEUTICALS INC$40.0M0.69%β€”β€”
0.7%
DSGNDESIGN THERAPEUTICS INC$39.7M0.69%$29.90$15.64-47.7%
0.7%

AttivitΓ  Trimestre su Trimestre

Q1 2021 vs. Q4 2020

Nuove Posizioni (7)

TickerEmittenteNozionaleDal Deposito
VRTXVERTEX PHARMACEUTICALS INC$300.9M+145.7%
ASCENDIS PHARMA$244.9M
APLSAPELLIS PHARMACEUTICALS INC$42.9M
DSGNDESIGN THERAPEUTICS INC$39.7M-47.7%
MRUSMERUS N V$13.9M
JNCEJOUNCE THERAPEUTICS INC$5.7M
LKFTGALAPAGOS NV$0.2M

Posizioni Chiuse (5)

TickerEmittenteNozionale
ASNDASCENDIS PHARMA$300.2M
ITOSITEOS THERAPEUTICS INC$15.6M
CUECUE BIOPHARMA INC$5.7M
ATNXATHENEX INC$4.1M
NKTRNEKTAR THERAPEUTICS$0.0M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SNDXSYNDAX PHARMACEUTICALS INC$45.9M+455.6%-2.4%
MNKDMANNKIND CORP$18.4M+114.3%
XLRNACCELERON PHARMA INC$208.5M+93.5%
FOLDAMICUS THERAPEUTICS INC$-86.8M+36.1%
XENEXENON PHARMACEUTICALS INC$22.3M+30.4%+240.6%
ACADACADIA PHARMACEUTICALS INC$-39.8M+28.2%+0.7%
SRPTSAREPTA THERAPEUTICS INC$-138.1M+22.9%-74.1%
MDGLMADRIGAL PHARMACEUTICALS INC$30.5M+16.3%+351.5%

Ridotte (5)

TickerEmittenteNozionaleVar. Azioni
DCPHDECIPHERA PHARMACEUTICALS INC$-34.1M-31.3%
BDTXBLACK DIAMOND THERAPEUTICS INC$-9.8M-31.2%
TVTXTRAVERE THERAPEUTICS INC$-17.9M-30.6%
ARNAARENA PHARMACEUTICALS INC$-40.9M-3.3%
TRILLIUM THERAPEUTICS INC$-24.1M-1.7%
← Torna agli Hedge Fund